| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Biomedical Research Laboratories, Sankyo Company, Limited, Tokyo, Japan;
Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, AL 35294; and
Department of Medicine, University of Regensburg, Regensburg, Germany
TRAIL has been proposed as an anti-inflammatory cytokine in animal models of rheumatoid arthritis (RA). Using two agonistic mAbs specific for TRAIL-R1 (DR4) and TRAIL-R2 (DR5), we examined the expression and function of these death receptors in RA synovial fibroblast cells. The synovial tissues and primary synovial fibroblast cells isolated from patients with RA, but not those isolated from patients with osteoarthritis, selectively expressed high levels of cell surface DR5 and were highly susceptible to anti-DR5 Ab (TRA-8)-mediated apoptosis. In contrast, RA synoviocytes did not show increased expression of TRAIL-R1 (DR4), nor was there any difference in expression of Fas between RA and osteoarthritis synovial cells. In vitro TRA-8 induced apoptosis of RA synovial cells and inhibited production of matrix metalloproteinases induced by pro-inflammatory cytokines. In vivo TRA-8 effectively inhibited hypercellularity of a SV40-transformed RA synovial cell line and completely prevented bone erosion and cartilage destruction induced by these cells. These results indicate that increased DR5 expression and susceptibility to DR5-mediated apoptosis are characteristic of the proliferating synovial cells in RA. As highly proliferative transformed-appearing RA synovial cells play a crucial role in bone erosion and cartilage destruction in RA, the specific targeting of DR5 on RA synovial cells with an agonistic anti-DR5 Ab may be a potential therapy for RA.
This article has been cited by other articles:
|
|
 |
|
  B Yazdani-Biuki, K Brickmann, U Langsenlehner, W Renner, M Truschnig, P Krippl, F Furst, W B Graninger, and H-P Brezinschek The Glu228Ala polymorphism in the ligand-binding domain of death receptor 4 is not associated with rheumatoid arthritis Ann Rheum Dis, July 1, 2008; 67(7): 1053 - 1054. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Terzioglu, A. Bisgin, A. D. Sanlioglu, M. Ulker, V. Yazisiz, S. Tuzuner, and S. Sanlioglu Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis Rheumatology, May 1, 2007; 46(5): 783 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kamata, S. Kamijo, A. Nakajima, A. Koyanagi, H. Kurosawa, H. Yagita, and K. Okumura Involvement of TNF-Like Weak Inducer of Apoptosis in the Pathogenesis of Collagen-Induced Arthritis J. Immunol., November 1, 2006; 177(9): 6433 - 6439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, H. Wang, Z. Wang, S. Makhija, D. Buchsbaum, A. LoBuglio, R. Kimberly, and T. Zhou Inducible Resistance of Tumor Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 2-Mediated Apoptosis by Generation of a Blockade at the Death Domain Function. Cancer Res., September 1, 2006; 66(17): 8520 - 8528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, C. Li, Y. Liu, W. Mei, S. Yu, C. Liu, L. Zhang, X. Cao, R. P. Kimberly, W. Grizzle, et al. JAB1 Determines the Response of Rheumatoid Arthritis Synovial Fibroblasts to Tumor Necrosis Factor-{alpha} Am. J. Pathol., September 1, 2006; 169(3): 889 - 902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Jungel, V Baresova, C Ospelt, B R Simmen, B A Michel, R E Gay, S Gay, C A Seemayer, and M Neidhart Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis Ann Rheum Dis, July 1, 2006; 65(7): 910 - 912. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, J. Wang, C. Liu, W. E. Grizzle, S. Yu, S. Zhang, S. Barnes, W. J. Koopman, J. D. Mountz, R. P. Kimberly, et al. Cleavage of p53-Vimentin Complex Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts Am. J. Pathol., September 1, 2005; 167(3): 705 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Morel, R. Audo, M. Hahne, and B. Combe Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Induces Rheumatoid Arthritis Synovial Fibroblast Proliferation through Mitogen-activated Protein Kinases and Phosphatidylinositol 3-Kinase/Akt J. Biol. Chem., April 22, 2005; 280(16): 15709 - 15718. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
